• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Platform Launches to Help Eliminate Biases in Decentralized Trials

by HITC Staff 01/20/2022 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Platform Launches to Help Clinical Raters Eliminate Biases in Decentralized Trials

What You Should Know:

– Obviohealth, a decentralized clinical trial platform, has launched a new AI-assisted clinical raters platform to eliminate biases from trials.

The platform Augmented ePRO (electronic patient-reported outcomes), has been designed to assist clinical raters to better score patient outcomes, without biases.

Why It Matters

As more trials take place virtually or decentralized, clinical researchers are at the mercy of the quality of the information provided by the trial participants/patients, who, let’s be honest, may not follow directions well. This is particularly challenging for decentralized clinical trials (DCTs) that involve a rating system, where the participants are required to follow a scale for reporting the spectrum of their symptom or whatever it is they are asked to report (ex. Do you feel like your cough is a 1 or an 8?) For these types of rating systems, which run on a scale from 1-10, or from good to bad, patients often rate their symptoms incorrectly. These trials are not as accurate as they could and should be; without a professional rater or system in place to verify the data inputted. 

New platform enables the capture and rating of more precise, real-time data for decentralized clinical trials

This health IT tool features an annotation option, which allows clinicians to detail why a rating was determined. These clinical notes can serve over time to program automatic ratings, which will lead to better clinical rating processes in the future. It enables patients involved in decentralized clinical trials (DCTs) to upload photos, audio, or video in real-time using a patient-centric app provided by ObvioHealth. Once the media is uploaded to the platform, each outcome is assessed and scored by a clinician and/or expert rater. By utilizing a media-focused platform, biases in clinical ratings can be eliminated exponentially.

“Both patients and expert clinical raters will benefit from this AI-assisted tech platform throughout the data collection and assessment processes,” said Ivan Jarry, co-founder and CEO of ObvioHealth. “But, with an eye towards the future, the annotation feature is especially useful,  allowing clinicians to easily capture nuances in patient ratings that can be used to train AI algorithms and lead to even better clinical rating processes in the future.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Decentralized Clinical Trials

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Knowledge Hub

 How Top Health Plans Use AI to Save Money and Work Smarter How Top Health Plans Use AI to Save Money and Work Smarter

 How to Build Hybrid Care Models Around Remote Patient Monitoring How to Build Hybrid Care Models Around Remote Patient Monitoring

Trending

Olive Secures $400M At A $4B Valuation to Support New Instant Claim Payment Solution

Olive Shutters Business After Sale to Waystar and Humata Health

Clinician Shortage Worsens Primary Care Crisis, Experts Reveal

Clinician Shortage Worsens Primary Care Crisis, Experts Reveal

FDA Grants Clearance for UltraSight's AI Cardiac Ultrasound

Israel Defense Forces to Utilize UltraSight’s PoCUS Devices in Combat

The Future of Biomarker-Based Therapy for Mental Disorder Care

The Future of Biomarker-Based Therapy for Mental Disorder Care

HLTH23: 6 Digital Health Executives Share Key Takeaways

6 Digital Health Executives Share Key Takeaways from HLTH23

HIMSS Appoints New Chief Financial Officer & General Counsel

HIMSS Appoints New Chief Financial Officer & General Counsel

GoodRx Now Offers Access to $35 Insulin to All Americans

GoodRx Now Offers Access to $35 Insulin to All Americans

Ozempic: From Diabetes Management to Potential Weight Loss Miracle

Ozempic: From Diabetes Management to Potential Weight Loss Miracle

Health M&A: Financial Distress Driving Q3 Healthcare Deals

Health M&A: Financial Distress Driving Q3 Healthcare Deals

GE HealthCare Inks $44M Contract with BARDA to Develop AI-Driven Ultrasound Tech

GE HealthCare Inks $44M Contract with BARDA to Develop AI-Driven Ultrasound Tech

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |